Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Androxal in Men With Secondary Hypogonadism (ZA-003)
NCT00962637Phase 3Completed
- Sponsor
- Repros Therapeutics Inc.
- Start
- Mar 2006
- Primary completion
- May 2007
- Countries
- 1
01
Overview
A Phase 3 trial of enclomiphene in secondary hypogonadism (HH), sponsored by Repros Therapeutics Inc.. Started Mar 2006; status: completed.
02
Drugs
enclomiphene
03
Conditions
secondary hypogonadism (HH)
Beyond the preview
Go deeper on NCT00962637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00962637.